- Home
- JMSB vs CATX Comparison
JMSB vs CATX Comparison
Compare JMSB & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMSB
- CATX
- Stock Information
- Founded
- JMSB 2005
- CATX 1983
- Country
- JMSB United States
- CATX United States
- Employees
- JMSB N/A
- CATX N/A
- Industry
- JMSB Major Banks
- CATX Medical/Dental Instruments
- Sector
- JMSB Finance
- CATX Health Care
- Exchange
- JMSB Nasdaq
- CATX Nasdaq
- Market Cap
- JMSB 246.7M
- CATX 239.0M
- IPO Year
- JMSB N/A
- CATX N/A
- Fundamental
- Price
- JMSB $18.00
- CATX $3.44
- Analyst Decision
- JMSB
- CATX Strong Buy
- Analyst Count
- JMSB 0
- CATX 10
- Target Price
- JMSB N/A
- CATX $13.00
- AVG Volume (30 Days)
- JMSB 15.8K
- CATX 1.5M
- Earning Date
- JMSB 07-23-2025
- CATX 08-11-2025
- Dividend Yield
- JMSB 2.78%
- CATX N/A
- EPS Growth
- JMSB 475.76
- CATX N/A
- EPS
- JMSB 1.24
- CATX N/A
- Revenue
- JMSB $54,782,000.00
- CATX $1,471,000.00
- Revenue This Year
- JMSB N/A
- CATX N/A
- Revenue Next Year
- JMSB N/A
- CATX N/A
- P/E Ratio
- JMSB $14.52
- CATX N/A
- Revenue Growth
- JMSB 50.81
- CATX N/A
- 52 Week Low
- JMSB $13.81
- CATX $1.60
- 52 Week High
- JMSB $26.52
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- JMSB 58.83
- CATX 60.53
- Support Level
- JMSB $17.30
- CATX $2.96
- Resistance Level
- JMSB $17.55
- CATX $3.77
- Average True Range (ATR)
- JMSB 0.35
- CATX 0.41
- MACD
- JMSB -0.01
- CATX 0.02
- Stochastic Oscillator
- JMSB 97.11
- CATX 73.78
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.